Health Scott Leffler Chief Financial Officer 4 Clover Health Second Quarter 2023 - Earnings Results Disclaimer 3 Financial Overview ● Q2 2023 revenue and MCR improvement driven by continued operational enhancements, a balanced plan design, clinical initiatives, and improved PPO Star rating 6 111.0% 107.9% 102.5% 102.8% 96.4% 92.4% 92.1% 86.3% 86.6% 83% - 85% 77.2% Q1'21 Q2'21 Q2'22 Q3'22 Q2*23 Q3'21 Q4'21 Q1'22 Q4'22 Q1'23 FY'23 Guidance 7 8 (1) Adjusted EBITDA is a non-GAAP financial measure. Please refer ...

Clover Health Investments, Corp. (NASDAQ:CLOV) Q2 2023 Earnings Conference Call August 8, 2023 5:00 PM ET Conference Call Participants Adam Ron - Bank of America Merrill Lynch Operator I would now like to turn the call over to Ryan Schmidt, Investor Relations for Clover Health. Please go ahead, sir. Good afternoon, everyone. Joining me on our call today to discuss the company's second quarter results are Andrew Toy, Clover Health's Chief Executive Officer; and Scott Leffler, the company's Chief Financial Of ...

________________________________________ Title of each class Trading Symbol(s) Name of each exchange on which registered Class A Common Stock, par value $0.0001 per share CLOV The NASDAQ Stock Market LLC For the quarterly period ended June 30, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-39252 ________________________________________ Registrant's telephone number, including area code: (201) 432-2133 Indicate by check mark whet ...

Conference Call Participants Ryan Schmidt Revenue for the Insurance line of business grew 14% to $317 million in the first quarter, and we continue to focus on Insurance revenue growth. This quarter, Non-Insurance revenue decreased to $206 million, primarily driven by our strategy to focus on a narrower group of participant providers. The first quarter adjusted SG&A was $86 million, a minimal increase over Q1 of 2022. The increase was driven by the rollout of our new rewards and incentives program but partl ...

________________________________________ For the transition period from ________ to ________ Clover Health Investments, Corp. (Exact Name of Registrant as Specified in its Charter) ________________________________________ Delaware 98-1515192 (State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.) Registrant's telephone number, including area code: (201) 432-2133 Trading If an emerging growth company, indicate by check mark if the registrant has elected not to use t ...

• Insight. Given the massive depth, breadth, and volume of data that we collect, it is critical to leverage technology to perform intelligent analytics. Analyzing this amount of data in real-time is very complex for any provider, but we have advanced our technology to perform these analytics in realtime. Our insight engine applies a combination of advanced machine learning and clinically-driven business rules to curate actionable insights for providers. Additional Products Built on Clover Assistant Platform ...

Clover Health Investments, Corp. (NASDAQ:CLOV) Q4 2022 Earnings Conference Call February 28, 2023 8:30 AM ET Ryan Schmidt - Investor Relations Andrew Toy - CEO Scott J. Leffler - CFO William Hoover - Canaccord Genuity Benjamin Rossi - Citigroup Kevin Fischbeck - Bank of America Good morning ladies and gentlemen and welcome to the Clover Health Fourth Quarter and Full Year 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the pr ...

These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those described in the risk factors set forth in Clover Health's most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (the "SEC"), including the Risk Factors section therein, and in our other filings with the SEC. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this presentation may not occur and actu ...

Health These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those described in the risk factors set forth in Clover's latest Annual Report on Form 10-K filed with the Securities and Exchange Commission (the "SEC") on February 28, 2022, including the Risk Factors section therein, and in our other filings with the SEC. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this presentation may no ...

Clover Health Investments, Corp. (NASDAQ:CLOV) Q3 2022 Earnings Conference Call November 7, 2022 5:00 PM ET Company Participants Ryan Schmidt - Investor Relations Vivek Garipalli - Chief Executive Officer Andrew Toy - President Scott Leffler - Chief Financial Officer Conference Call Participants Jason Cassorla - Citi Richard Close - Canaccord Genuity Kevin Fischbeck - Bank of America Whit Mayo - SVB Securities. Operator Please stand-by, your program is about to begin. Ladies and gentlemen, good afternoon, a ...